Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2, Randomized, Controlled Assessment of the Safety Of Gintuit™ Versus Bio-Gide® in Subjects Requiring Socket Grafting

NCT01929954 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.

NCT NCT01929954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01929954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2, Randomized, Controlled Assessment of the Safety Of Gintuit™ Versus Bio-Gide® in Subjects Requiring Socket Grafting
Lead sponsor
Organogenesis
Phase
Phase 1/2
Overall status
Terminated
Start date
July 31, 2013
Completion date
March 31, 2015
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

edentulous alveolar ridge